These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 1349662

  • 1. The treatment of hairy cell leukemia: an update.
    Golomb HM, Ratain MJ, Mick R, Daly K.
    Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
    [Abstract] [Full Text] [Related]

  • 2. Hairy cell leukemia 1992.
    Spielberger RT, Golomb HM.
    Leukemia; 1992 Nov; 6 Suppl 4():142-6. PubMed ID: 1279327
    [Abstract] [Full Text] [Related]

  • 3. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Nov; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 4. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL, Pellegrini C, Stefoni V, Derenzini E, Gandolfi L, Broccoli A, Argnani L, Quirini F, Pileri S, Baccarani M.
    Cancer; 2010 Oct 15; 116(20):4788-92. PubMed ID: 20597132
    [Abstract] [Full Text] [Related]

  • 5. Hairy cell leukaemia: review of treatment.
    Kurzrock R, Talpaz M, Gutterman JU.
    Br J Haematol; 1991 Oct 15; 79 Suppl 1():17-20. PubMed ID: 1718389
    [Abstract] [Full Text] [Related]

  • 6. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep 18; 34(879):89-90. PubMed ID: 1355592
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M, Machaczka M, Załuska A, Skotnicki AB.
    Przegl Lek; 1998 Sep 18; 55(7-8):400-6. PubMed ID: 10021885
    [Abstract] [Full Text] [Related]

  • 11. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V.
    Leukemia; 2004 Sep 18; 18(9):1476-81. PubMed ID: 15229616
    [Abstract] [Full Text] [Related]

  • 12. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD, Carrera CJ, Carson DA, Beutler E.
    N Engl J Med; 1990 Apr 19; 322(16):1117-21. PubMed ID: 1969613
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S.
    Acta Haematol Pol; 1995 Apr 19; 26(2):139-43. PubMed ID: 7653218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Red cell distribution width (RDW) as a marker of disease activity in patients with hairy cell leukemia.
    Chrobák L, Zák P, Podzimek K, Stránský P.
    Acta Medica (Hradec Kralove); 1998 Apr 19; 41(1):23-6. PubMed ID: 9588069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.